Pravastatin and Protease Inhibitors in HIV-infected Patients

StatusCompleted
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Pravastatin (drug) (Drug) to Placebo (Drug), Pravastatin (drug) (Drug)
    • Study arms: 0 to 2
    v5
  2. Enrollment target: 60 to 21
    • Primary endpoint revised
    • Study title expanded, about 3 words
    v4
  3. Trial status: Terminated to Completed
    • Secondary endpoints revised (4)
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the use of pravastatin in hypercholesterolemic HIV-infected patients treated with protease inhibitors in a randomised double blind study.
Trial Details
NCT Number NCT00221754
Lead Sponsor University Hospital, Bordeaux
Collaborators: Ministry of Health, France
Conditions
(from sponsor)		 HIV Infection, Hypercholesterolemia
Related terms HIV Infections, Hypercholesterolemia
Enrollment 21 participants
Start Date
Study Completion (estimated)
Updated on ClinicalTrials.gov